Results 21 to 30 of about 2,661 (133)

Based on breast CEUS parameters combined with serum CA153, a nomogram model was constructed to predict the molecular classification of breastcancer

medRxiv
AbstractObjectiveTo analyze the role of contrast-enhanced ultrasound (CEUS) parameters combined with serum tumor marker CA153 in the prediction of Breast Cancer (BC) molecular typing.MethodsFrom January 2020 to January 2023, 120 BC patients diagnosed in our hospital were studied.
Yanlei Ji, Zhen Han, Yong Zhang, Wenwen Sun   +3 more
openaire   +2 more sources

Electrochemical detection of CEA and CA153 Lung Cancer Markers Based on ZnO/Porous Graphene Oxide Composite Biosensor

International Journal of Electrochemical Science, 2022
In this work, zinc oxide/porous graphene oxide (ZnO/HGO) composites were prepared by wet chemistry for the construction of electrochemical sensors for the tumor markers carcinoembryonic antigen (CEA) and CA153.
Wencheng Che, Xuekai Zhao, Fei Wang, Tiejun Ma, Kai Zhao   +4 more
openaire   +2 more sources

The Individual Fluctuation Range and Significance of CA153 in Breast Cancer

Journal of Surgery, 2021
Background: To observe the individual patient fluctuation range of carbohydrate antigen-153 in breast cancer and find the individual standard of carbohydrate antigen-153 to follow-up. Methods: From January 2014 to December 2017, 138 patients with stage 0-
Ping Chen, J. Liu, Linping Huang, Meng Yang   +3 more
openaire   +2 more sources

Electrochemical Immunoassay for Breast Cancer Markers CA153 Determination Based on Carbon Nanotubes modified Electrode

International Journal of Electrochemical Science, 2017
Wensheng Wang, Shuai Li, Guannan Zhang, Jianxin He, Zhiqiang Ma   +4 more
openaire   +2 more sources

A homogeneous biosensor for carbohydrate antigen 153 detection in human serum based on upconversion fluorescence resonance energy transfer

Talanta Open, 2022
Quantitative determination of carbohydrate antigen 153 (CA153) in human serum plays an important role in early diagnosis of breast cancer. In this work, a highly sensitive and selective biosensor for CA153 detection was developed based on a fluorescent ...
Tao Liang, Xiuqing Ma, Xiaojing Zhang, Miantai Ye, Yanying Wang, Chunya Li   +5 more
doaj   +1 more source

Strategies for five tumour markers in the screening and diagnosis of female breast cancer

Frontiers in Oncology, 2023
ObjectiveThis study evaluated the diagnostic value of different combinations of five commonly used tumour markers and screened the best combination of tumour markers.MethodsRegression analysis was used to evaluate 185 patients with suspected breast ...
Jun Luo, Jianbo Xiao, Yuwei Yang, Gang Chen, Dong Hu, Jiawei Zeng   +5 more
doaj   +1 more source

The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients

Frontiers in Medicine, 2022
BackgroundThe changes in inflammation and tumor biomarkers are associated with the anti-tumor immunological processes. Early detection and intervention are of great significance to the clinical management of cancer-related diseases.
Sheng Yu, Jingjing Zhao, Menglian Wang, Guo Cheng, Wen Li, Lingxue Tang, Senbang Yao, Lulian Pang, Xiangxiang Yin, Yanyan Jing, Huaidong Cheng   +10 more
doaj   +1 more source

Genome-wide association study of serum tumor markers in Southern Chinese Han population

BMC Cancer, 2022
Background Serum indicators AFP, CA50, CA125, CA153, CA19-9, CEA, f-PSA, SCC-Ag have been confirmed as tumor markers (TMs). We conducted a genome-wide association study on 8 tumor markers of our 427 Han population in southern China, in order to identify ...
Xiukuan Li, Fenghua Bai, Xingwei Wei, Tianbo Jin, Chen Li, Yutian Zhang, Mei Lin, Xiaoli Zhou, Yufei Xie, Chanyi He, Qi Lin, Ping He, Shuyuan Chu, Yipeng Ding   +13 more
doaj   +1 more source

Prolonged Use of Aprepitant in Metastatic Breast Cancer and a Reduction in CA153 Tumour Marker Levels

International Journal of Cancer and Clinical Research, 2016
C l i n M e d International Library Citation: Lee M, McCloskey M, Staples S (2016) Prolonged Use of Aprepitant in Metastatic Breast Cancer and a Reduction in CA153 Tumour Marker Levels.
Mark Lee
openaire   +2 more sources

Serological Diagnosis of Liver Metastasis in Patients with Breast Cancer

Cancer Biology & Medicine, 2012
Objective: To diagnose and explore the serological diagnostic factors for liver metastasis in patients with breast cancer before symptoms occur. Methods: A total of 430 female in-patients with breast cancer of stages 0 to IIIC who came to Tianjin Medical
Rui Cao, Li-ping Wang
doaj   +3 more sources